Haohai
Medical absorbable biomedical R & D company
Haohai, founded in January, 2007 and headquartered in Shanghai, is a medical absorbable biomedical researcher. The founder is Hou Yongtai. Listed on the HKEX on April 4, 2015, the company's major shareholders are Jiang Wei, You Jie and Lou Guoliang. Rivals that have direct and indirect competition with Haohai include Bloomage, Boai Nky, Pharm Agra Holding, Mylan, etc.
Xinyi biological completed 150 million round B financing, and Lilly Asia Fund led investment in Huachuang capital, hillhood venture capital and other follow-up investment
Another protein component special medical food was approved, and the total number of approved products increased to 57
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Improving service quality and enabling industrial innovation!
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Consumer Discretionary, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
Plan to raise $4 billion! Jingdong health runs IPO
Drug Innovator Asieris Nabs CNY 700 Million Series D
HaoYuan Chemexpress Files for IPO on the Star Market
Beijing Immunochina Pharmaceutical Closes Series C+ at CNY 100 Mn
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM
Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
With UBS as Bookrunner, Haohai Biotech Goes Public on Star Market
The firm, which is currently listed in Hong Kong, has priced its Shanghai IPO at CNY 89.23 (USD 12.62) a share – the highest listing price on the new sci-tech board to date.
Oct 21, 2019 05:47 PM
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Tongshu Gene Closes Series B of Multi-Hundreds Millions
Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn
Biotech IMAB’s In-Process New Drug Enters Clinical Trials